An experimental vaccine produced by pharmaceutical giants GlaxoSmithKline has reduced by half the risk of African children getting malaria in a major clinical trial. This makes it likely to become the world?s first major breakthrough against the deadly disease. �
Obama administration Housing market Alex Reid Regulators China Norway
No comments:
Post a Comment